Board Meeting4 Nov 2026, 01:23 pm
Biocon Ltd Board Approves Unaudited Financial Results
AI Summary
Biocon Ltd announced that its Board of Directors has approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The results are prepared as per Indian Accounting Standards (Ind-AS) on a standalone and consolidated basis. The Board also noted the resignation of Dr. Mandar Shrikant Ghatnekar as Chief Technology Officer, effective December 31, 2026, and approved the appointment of Mr. Mukesh Rathi as the new Chief Technology Officer, effective January 01, 2027. The company will make these results available on its website.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results are standalone and consolidated, prepared under Ind-AS.
- CTO Dr. Mandar Shrikant Ghatnekar resigned, effective Dec 31, 2026.
- Mr. Mukesh Rathi appointed as new CTO, effective Jan 01, 2027.
Price Impact
More from BIOCON